Form D · Biotechnology
ADURO BIOTECH, INC.
Berkeley, CA · CIK 0001435049
Offering snapshot reported Jan 5, 2015 · SEC filing
- Reported sold
- $51.4M Offering amount: $51.4M
- Investors reported
- 28 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 19, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 5, 2015 | Initial | $51,388,002 | No comparison | 28 | SEC filing |
| Jun 13, 2014 | Initial | $40,602,333 | No comparison | 25 | SEC filing |
| Sep 10, 2013 | Initial | $7,000,000 | No comparison | 1 | SEC filing |
| Feb 12, 2013 | Amendment | $25,573,536 | $23,344,862vs Apr 22, 2011 | 11 | SEC filing |
| Dec 5, 2011 | Initial | $512,100 | No comparison | 1 | SEC filing |
| Apr 22, 2011 | Initial | $2,228,674 | No comparison | 9 | SEC filing |
| Apr 9, 2010 | Initial | $768,847 | No comparison | 14 | SEC filing |
| Nov 17, 2009 | Initial | $1,175,000 | No comparison | 9 | SEC filing |
| Nov 17, 2009 | Initial | $1,775,000 | No comparison | 13 | SEC filing |
| May 8, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.4M
- Finders' fees
- $0
- Form D file number
- 021-231435
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Leerink Partners LLC | 39011 |
Source: Form D, filed Jan 5, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dirk G. Brockstedt | Executive |
| Gerald David Chan | Director |
| Thomas W. Dubensky | Executive |
| David Fischell | Director |
| William E. Gibson | Director |
| William Greenman | Director |
| Ross Haghighat | Director |
| Stephen Isaacs | Director, Executive |
| Jennifer Lew | Executive |
| Rudy Mazzocchi | Director |
| Frank Mc Cormick | Director |
| S. David Model | Executive |
| Seth David Model | Executive |
| Stephanie O'brien | Director |
| Drew Pardoll | Director |
| Christopher D. Ray | Director |
| Gregory W. Schafer | Executive |
| Dale H. Stevens | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
626 Bancroft Way Suite 3 C
Berkeley, CA, 94710
Berkeley, CA, 94710